April 23, 2012 (Atlanta, GA) — Methadone and buprenorphine are viable analgesic treatment options for patients with chronic pain and comorbid opioid addiction. However, when it comes to safety, ...

For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, but overall evidence for pain outcomes in these patients is low, according ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Buprenorphine may be as effective as conventional analgesia in older adults with acute pain, with reduced opioid consumption and breakthrough analgesia. In older adults, buprenorphine was found to ...

Buprenorphine is a treatment medication that decreases mortality risks among people with opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US. Insurance restrictions ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Departments of Veterans Affairs and Defense recently updated their clinical practice guidelines for the ...

In a synopsis of the latest U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) clinical practice guideline, published online Feb. 14 in the Annals of Internal Medicine, ...

A new study shows that reducing restrictions on buprenorphine, a medication that can treat opioid use disorder, did not lead to an increase in overdose deaths involving the treatment. The findings may ...

In December 2022, Congress repealed the “X-waiver” requirement, which had limited medical providers’ ability to prescribe buprenorphine-naloxone, one of the three medications approved by the Food and ...

Signing into law a change that can prevent thousands of Americans from dying of opioid overdoses should have been met with fanfare. Instead, it not only slid under the media radar but hasn’t been ...